Two Cases of Acute Polyarthritis Secondary to Intravesical BCG Adjuvant Therapy for Superficial Bladder Cancer

被引：0
|
作者：
N. P. Pardalidis
A. G. Papatsoris
E. V. Kosmaoglou
C. Georganas
机构：
[1] Hellenic Airforce and VA General Hospital,
[2] Athens,undefined
[3] Greece,undefined
来源：
Clinical Rheumatology | 2002年 / 21卷
关键词：
Key words:Arthritis – Bacillus Calmette–Guérin – Superficial bladder cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We report two cases of acute polyarthritis secondary to intravesical BCG therapy for superficial bladder cancer. This extremely rare complication requires high clinical suspicion and responds well to non-steroidal anti-inflammatory drugs and conservative management.
引用
收藏
页码：536 / 537
页数：1
相关论文
共 50 条
  • [21] Low dose BCG as adjuvant therapy for superficial bladder cancer and literature review
    Cheng, CW
    Ng, MT
    Chan, SY
    Sun, WH
    ANZ JOURNAL OF SURGERY, 2004, 74 (07) : 569 - 572
  • [22] INTRAVESICAL THERAPY IN SUPERFICIAL BLADDER-CANCER
    WITJES, JA
    MULDERS, PFA
    DEBRUYNE, FMJ
    UROLOGY, 1994, 43 (02) : 2 - 5
  • [23] Adjuvant intravesical therapy and improved survival among elderly patients with superficial bladder cancer
    Spencer, Benjamin A.
    Mohile, Supriya G.
    Hershman, Dawn
    Wang, Jian
    Herr, Harry W.
    Benson, Mitchell C.
    Neugut, Alfred I.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 519 - 519
  • [24] AUTOMATED FLOW-CYTOMETRY TO MONITOR INTRAVESICAL BCG THERAPY OF SUPERFICIAL BLADDER-CANCER
    KLEIN, FA
    HERR, HW
    WHITMORE, WF
    PINSKY, CH
    OETTGEN, HT
    MELAMED, MR
    UROLOGY, 1981, 17 (04) : 310 - 314
  • [25] The current status of intravesical therapy for superficial bladder cancer
    Patard, JJ
    Rodriguez, A
    Lobel, B
    CURRENT OPINION IN UROLOGY, 2003, 13 (05) : 357 - 362
  • [26] Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer
    E. C. de Boer
    L. Somogyi
    G. J. W. de Ruiter
    Th. M. de Reijke
    K. -H. Kurth
    D. H. J. Schamhart
    Urological Research, 1997, 25 : 31 - 34
  • [27] INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER-CANCER - IS IT A WASH
    KILBRIDGE, KL
    KANTOFF, P
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 1 - 4
  • [28] What have we learned after 30 years of BCG intravesical therapy for superficial bladder cancer?
    Tobias-Machado, Marcos
    Pereira Esteves, Marcos Adolfo
    Starling, Eduardo Simoes
    Lima Pompeo, Antonio Carlos
    Wroclawski, Eric Roger
    EINSTEIN-SAO PAULO, 2009, 7 (04): : 515 - 519
  • [29] Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer
    deBoer, EC
    Somogyi, L
    deRuiter, GJW
    deReijke, TM
    Kurth, KH
    Schamhart, DHJ
    UROLOGICAL RESEARCH, 1997, 25 (01): : 31 - 34
  • [30] Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer - Editorial comment
    O'Donnell, MA
    UROLOGY, 2001, 57 (04) : 621 - 622
12345